EU makes Sanofi commitments binding over flu vaccine disparagement

The European Commission accepted binding commitments from Sanofi to resolve antitrust concerns over alleged disparagement of rival flu vaccine Fluad in Germany and France. Sanofi will adjust practices to ensure fair competition for the enhanced flu vaccine market. This marks a regulatory action with potential implications for pharmaceutical competition and pricing.